Table 2b.
Controls | Schizophrenia Patients | |||
---|---|---|---|---|
Target ROI | Placebo | Nicotine | Placebo | Nicotine |
Left IFG | 0.23 (0.043) | 0.21 (0.036) | 0.29 (0.033) | 0.25 (0.050) |
Right IFG | 0.11 (0.023) | 0.14 (0.026) | 0.21 (0.025) | 0.22 (0.042) |
Controls | Schizophrenia Patients | |||
---|---|---|---|---|
Target ROI | Placebo | Nicotine | Placebo | Nicotine |
Left IFG | 0.23 (0.043) | 0.21 (0.036) | 0.29 (0.033) | 0.25 (0.050) |
Right IFG | 0.11 (0.023) | 0.14 (0.026) | 0.21 (0.025) | 0.22 (0.042) |